Altered Serum Metabolites in Primary MF Present Opportunities for Antioxidant Therapy
Altered serum metabolites in primary MF present opportunities for antioxidant therapy, as patients with PMF have a different metabolic makeup.
Read More
Ad Code: Vonjo - Myelofibrosis - Sep Display Banners HCP Wallboard Extension - 106833
How Does Splenomagaly Impact Post-HCTs?
In a study published in the Journal of Clinical Oncology, researchers evaluated the impact of splenomegaly on post hematopoietic cell transplant (HCT) outcomes in patients with myelofibrosis using precise 3D volumetric...
Read More
Analyzing Thrombotic Risk Factors
Recent findings underscore the need for clinicians to stratify arterial and venous thrombosis risks separately in patients with myelofibrosis.
Read MoreHaploidentical, Related, Unrelated: Does Donor Type Impact Transplant Outcomes?
Matched sibling donors aside, donor type was not associated with significant differences in overall survival in patients with myelofibrosis who underwent hematopoietic cell transplantation (HCT), according to study results...
Read MoreEmbracing Whole-Person Health for Physician & Patient Wellness
On a recent episode of PeerPOV: The Pulse on Medicine, Jeffrey Gladd, MD, chief medical officer at Fullscript, shared his personal journey with whole person health and how it has impacted his practice. I ’m a trained family...
Read More